CS logo
small CS logo
New Cross Hospital; Dept. Of Haematology

Wolverhampton, United Kingdom
Hospital in Wolverhampton, England
Wolverhampton Rd, Heath Town, Wolverhampton WV10 0QP

About New Cross Hospital; Dept. Of Haematology


New Cross Hospital is a hospital in the Heath Town district of Wolverhampton, West Midlands, England. It is located to the east of the city centre in Wednesfield and is managed by the Royal Wolverhampton NHS Trust.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at New Cross Hospital; Dept. Of Haematology


During the past decade, New Cross Hospital; Dept. Of Haematology conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study to Demonstrate the Efficacy and Safety of Propranolol Oral Solution in Infants With Proliferating Infantile Hemangiomas Requiring Systemic Therapy
2010-01-01
2013-11-01
Completed
512
Clinical Trial of Rapamycin and Irinotecan in Pediatric Patients With Refractory Solid Tumors
2011-04-22
2013-02-20
Completed
42
Vincristine and Irinotecan With or Without Temozolomide in Children and Adults With Refractory/Relapsed Rhabdomyosarcoma
2012-01-01
2019-05-01
Completed
120
A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years
2011-09-27
2016-08-10
Completed
295
GRASPA (Erythrocytes Encapsulating L-asparaginase) in Patients With Relapse of Acute Lymphoblastic Leukemia
2009-12-01
2016-10-01
Completed
85
Study of OnabotulinumtoxinA (BOTOX®) for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
2013-07-02
2018-10-11
Completed
114
A Long-Term Extension Study of OnabotulinumtoxinA (BOTOX®) for Urinary Incontinence Due to Neurogenic Detrusor Overactivity
2014-01-11
2019-10-03
Completed
95
Safety, PK/PD (Pharmacokinetics/Pharmacodynamics) and Efficacy of ACP-001 Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
2013-07-01
2015-09-01
Completed
53

Rows per page:

1–20 of 20

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "New Cross Hospital; Dept. Of Haematology" #1 collaborator was "Fondazione Italiana Linfomi ONLUS" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at New Cross Hospital; Dept. Of Haematology


According to Clinical.Site data, the most researched conditions in "New Cross Hospital; Dept. Of Haematology" are "B-cell Lymphoma" (1 trials), "Diffuse Large B-Cell Lymphoma" (1 trials), "Non-Hodgkin's Lymphoma" (1 trials) and "Relapsed or Refractory Follicular Lymphoma, Relapsed or Refractory Diffuse Large B-Cell Lymphoma" (1 trials). Many other conditions were trialed in "New Cross Hospital; Dept. Of Haematology" in a lesser frequency.

Clinical Trials Intervention Types at New Cross Hospital; Dept. Of Haematology


Most popular intervention types in "New Cross Hospital; Dept. Of Haematology" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Rituximab" (3 trials), "Cyclophosphamide" (2 trials), "Doxorubicin" (2 trials), "Obinutuzumab" (2 trials) and "Vincristine" (2 trials). Other intervention names were less common.

Clinical Trials Genders at New Cross Hospital; Dept. Of Haematology


The vast majority of trials in "New Cross Hospital; Dept. Of Haematology" are 4 trials for "All" genders.

Clinical Trials Status at New Cross Hospital; Dept. Of Haematology


Currently, there are NaN active trials in "New Cross Hospital; Dept. Of Haematology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in New Cross Hospital; Dept. Of Haematology, undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in New Cross Hospital; Dept. Of Haematology, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status